Subscribe to RSS
DOI: 10.1055/s-0030-1259913
Synthesis of the Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitor 5,6-Dibromo-2′-demethylaplysinopsin
Publication History
Publication Date:
15 March 2011 (online)
Abstract
The first synthesis of the selective neuronal nitric oxide synthase (nNOS) inhibitor 5,6-dibromo-2′-demethylaplysinopsin is described. The rare 5,6-dibromoindole moiety was constructed using a previously unused dibromination of an indole-3-carboxylate, the product of which was verified by X-ray crystallography. It was discovered the natural product was characterised as its trifluoroacetate salt in the isolation report.
Key words
5,6-dibromoindole - aplysinopsin - neuronal nitric oxide synthase (nNOS) - heterocycle
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Ishikura M.Yamada K.Abe T. Nat. Prod. Rep. 2010, 27: 1630 -
1b
Ishikura M.Yamada K. Nat. Prod. Rep. 2009, 26: 803 -
1c
Higuchi K.Kawasaki T. Nat. Prod. Rep. 2007, 24: 843 -
1d
Kawasaki T.Higuchi K. Nat. Prod. Rep. 2005, 22: 761 -
1e
Somei M.Yamada F. Nat. Prod. Rep. 2005, 22: 73 - 2
Humphrey GR.Kuethe JT. Chem. Rev. 2006, 106: 2875 -
3a
Van Lear GE.Morton GO.Fulmor W. Tetrahedron Lett. 1973, 299 -
3b
Djura P.Stierle DB.Sullivan B.Faulkner DJ.Arnold E.Clardy J. J. Org. Chem. 1980, 45: 1435 -
3c
Kochanowska A.Rao KV.Childress S.El-Alfy A.Matsumoto RR.Kelly M.Stewart GS.Sufka KJ.Hamann MT. J. Nat. Prod. 2008, 71: 186 - 4
Tasdemir D.Bugni TS.Mangalindan GC.Concepción GP.Harper MK.Ireland CM. Z. Naturforsch., C 2002, 57: 914 - 5
Lee N.-K.Fenical W.Lindquist N. J. Nat. Prod. 1997, 60: 697 -
6a
Reyes F.Fernández R.Rodríguez A.Francesh A.Taboada S.Ávila C.Cuevas C. Tetrahedron 2008, 64: 5119 -
6b
Šíša M.Pla D.Altuna M.Francesch A.Cuevas C.Albericio F.Álvarez M. J. Med. Chem. 2009, 52: 6217 -
6c
A semi-synthesis of aplycyanin F (7) has been achieved by acetylation (Ac2O, py) of aplycyanin E (6); see ref. 6a.
- 7
Gompel M.Leost M.de Kier Joffe EB.Puricelli L.Franco LH.Palermo J.Meijer L. Bioorg. Med. Chem. Lett. 2004, 14: 1703 -
8a
Appleton DR.Page MJ.Lambert G.Berridge MV.Copp BR. J. Org. Chem. 2002, 67: 5402 -
8b
Appleton DR.Copp BR. Tetrahedron Lett. 2003, 44: 8963 - 9
Aoki S.Ye Y.Higuchi K.Takashima A.Tanaka Y.Kitagawa I.Kobayashi M. Chem. Pharm. Bull. 2001, 49: 1372 -
10a
Uehara T.Nakamura T.Yao D.Shi ZQ.Gu Z.Ma Y.Masliah E.Nomura Y.Lipton SA. Nature (London) 2006, 441: 513 -
10b
Chung KK.Thomas B.Li X.Pletnikova O.Troncoso JC.Marsh L.Dawson VL.Dawson TM. Science 2004, 304: 1328 -
10c
Cho DH.Nakamura T.Fang J.Cieplak P.Godzik A.Gu Z.Lipton SA. Science 2009, 324: 102 -
10d
Hantraye P.Brouillet E.Ferrante R.Palfi S.Dolan R.Matthews RT.Beal MF. Nature Med. 1996, 2: 1017 -
11a
Calabrese V.Mancuso C.Calvani M.Rizzarelli E.Butterfield DA.Stella AM. Nature Rev. Neurosci. 2007, 8: 766 -
11b
Contestabile A.Monti B.Contestabile A.Ciani E. Curr. Med. Chem. 2003, 10: 2147 -
11c
Estevez AG.Jordan J. Ann. N. Y. Acad. Sci. 2002, 962: 207 -
12a
Ferriero DM.Holtzman DM.Black SM.Sheldon RA. Neurobiol. Dis. 1996, 3: 64 -
12b
Tan S.Bose R.Derrick M. Free Radical Biol. Med. 2001, 30: 1045 -
12c
Derrick M.Drobyshevsky A.Ji X.Tan SA. Stroke 2007, 38: 731 -
12d
Derrick M.Luo NL.Bregman JC.Jilling T.Ji X.Fisher K.Gladson CL.Beardsley DJ.Murdoch G.Back SA.Tan S. J. Neurosci. 2004, 24: 24 - 13
Huang Z.Huang PL.Panahian N.Dalkara T.Fishman MC.Moskowitz MA. Science 1994, 265: 1883 - For two excellent reviews covering the chemistry and biology of the aplysinopsin alkaloids, see:
-
14a
Stanovnik B.Svete J. Mini-Rev. Org. Chem. 2005, 2: 211 -
14b
Bialonska D.Zjawiony JK. Mar. Drugs 2009, 7: 116 -
15a
Da Settimo A.Saettone MF.Nannipieri E.Barili P. Gazz. Chim. Ital. 1967, 97: 1304 -
15b
Da Settimo A.Primofiore G.Ferrarini PL.Franzone JS.Cirillo R.Cravanzola C. Eur. J. Med. Chem. 1983, 18: 261 -
16a
Miki Y.Umemoto M.Nakamura M.Hibino H.Ohkita N.Kato A.Aoki Y. Heterocycles 2006, 68: 1893 -
16b
Buszek KR.Luo D.Kondrashov M.Brown N.VanderVelde D. Org Lett. 2007, 9: 4135 -
16c
Brown N.Luo D.VanderVelde D.Yang S.Brassfield A.Buszek KR. Tetrahedron Lett. 2009, 50: 63 - 17
Majima R.Kotake M. Ber. 1930, 63: 2237 -
18a
Leggetter BE.Brown RK. Can. J. Chem. 1960, 38: 1467 -
18b
Da Settimo A.Antonio SV.Primofiore G.Biagi G.Veneziano C. Gazz. Chim. Ital. 1977, 107: 367 - 21
Roué N.Bergman J. Tetrahedron 1999, 55: 14729 - 22
Kenyon GL.Rowley GL. J. Am. Chem. Soc. 1971, 93: 5552 -
23a
Djura P.Faulkner DJ. J. Org. Chem. 1980, 45: 735 -
23b
Guella G.Mancini I.Zibrowius H.Pietra F. Helv. Chim. Acta 1988, 71: 773 -
23c
Guella G.Mancini I.Zibrowius H.Pietra F. Helv. Chim. Acta 1989, 72: 1444 - 24
Reddy YT.Sekhar KR.Sasi N.Reddy NP.Freeman ML.Crooks PA. Bioorg. Med. Chem. Lett. 2010, 20: 600 -
25a
Schuisky P.Twistel W.Grivas S. Heterocycles 1998, 48: 1431 -
25b
Grivas S.Schuisky P. Heterocycles 1998, 48: 1575 - 27
Burke CP.Swingle MR.Honkanen RE.Boger DL. J. Org. Chem. 2010, 75: 7505
References and Notes
Crystallographic data (reference number
CCDC 804778) can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html [or
from the Cambridge Crystallo-
graphic Data Centre, 12 Union
Road, Cambridge, CB21EZ, UK; fax: +44 (1223)336033; or
deposit@ccdc.cam.ac.uk].
5,6-Dibromoindole-3-carbaldehyde is a side product (5% yield) obtained from treating indole-3-carbaldehyde with bromine in the presence of iron; see ref. 15a.
26See Supporting Information for full details.